Market Cap

Phibro Animal Health Corporation Market Capitalization:

$1.51 Billion

USD as of Jan. 1, 2026

business Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation Main Stock Listing

NASDAQ: PAHC

Market Capitalization History of Phibro Animal Health Corporation

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Phibro Animal Health Corporation market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.51 B 70.37%
Jan. 1, 2025 $887.4 M 93.89%
Jan. 1, 2024 $457.7 M -23.08%
Jan. 1, 2023 $595.0 M -23.89%
Jan. 1, 2022 $781.7 M -6.94%
Jan. 1, 2021 $840.0 M -12.56%
Jan. 1, 2020 $960.7 M -24.02%
Jan. 1, 2019 $1.26 B -8.31%
Jan. 1, 2018 $1.38 B 27.53%
Jan. 1, 2017 $1.08 B -20.42%
Jan. 1, 2016 $1.36 B 22.76%
Jan. 1, 2015 $1.11 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Phibro Animal Health Corporation Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Phibro Animal Health Corporation has the following listings and related stock indices.


Stock: NASDAQ: PAHC

Stock: FSX: PB8

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.